Credo: $3,000 Per GPU, And That's Not Even My Buy Thesis

Credo Technology is rated a cautious Buy with a FY2029 price target of $274, implying 26% upside. Its core AI connectivity business delivered 115% year-over-year revenue growth in Q1 FY2027. OmniConnect offers additional upside potential but is excluded from the valuation because deployment visibility remains limited.

Analysis

The key question is not whether AI connectivity demand is growing, but how much of that growth converts into durable, diversified earnings before customer programs or competing architectures change. Rapid expansion can amplify both operating leverage and downside: a pause in deployments, pricing pressure, or a shift in platform design could hit expectations harder than the current growth rate implies. Credo also competes for design wins in a field that includes larger connectivity suppliers such as Broadcom and Marvell, and specialists such as Astera Labs; the relevant signal is sustained share capture, not category growth alone.

Over the next 1–3 months, monitor forward revenue guidance, gross-margin direction, customer concentration and evidence that new programs are shipping at scale. Over 6–18 months, memory-connectivity optionality matters only if deployment visibility improves; until then, treating it as a free earnings stream risks paying twice for an unproven catalyst. A broader slowdown in hyperscaler investment, customer insourcing, or faster-than-expected substitution would reverse the thesis. The contrarian risk is that investors extrapolate current growth while underweighting durability and concentration; the upside case is that successful platform adoption creates an additional growth leg not yet reflected in estimates. No supplied evidence establishes either outcome.

Key Decisions for Investors

• Do not chase a sharp near-term rally on the growth narrative alone. Consider a staged CRDO long only if exposure is consistent with high-growth semiconductor volatility; add on evidence of continued shipment growth and stable margins rather than on platform announcements.
• Treat OmniConnect as a watch item, not base-case value. Reassess only after verifiable deployment milestones, customer adoption and contribution to reported revenue are disclosed.
• For the next earnings update, track forward revenue guidance, gross-margin trend and customer/program concentration. A material slowdown in guidance or margin deterioration would falsify the near-term momentum thesis and warrant reducing exposure.
• If seeking sector exposure while limiting single-name risk, compare CRDO with a diversified semiconductor vehicle rather than assuming the connectivity market’s growth accrues to CRDO; no relative-value trade is supported without valuation, positioning and peer-growth data.